Description
🌻 OXY-NUT-AMRIT Syrup 300 ml | Lycopene with Ginseng, Multivitamin & Multimineral SyrupÂ
Support your daily nutrition with OXY-NUT-AMRIT Syrup from Medi-Access. Formulated with Lycopene, Ginseng, Multivitamins, and Multiminerals, this antioxidant-rich nutritional supplement helps support immunity, energy production, overall vitality, and general well-being. It is an ideal daily supplement for individuals seeking comprehensive nutritional support and a healthy lifestyle.
Key Features of OXY-NUT-AMRIT
– Enriched with Lycopene and Ginseng
– Fortified with essential multivitamins and multiminerals
– Powerful antioxidant nutritional supplement
– Helps support immunity and overall wellness
– Pleasant syrup formulation for easy consumption
– Suitable for daily nutritional supplementation
Benefits of OXY-NUT-AMRIT
– Helps meet daily nutritional requirements
– Supports immune health and overall vitality
– Provides antioxidant protection against oxidative stress
– Helps maintain energy and stamina
– Supports overall health and well-being
Product Composition
| Ingredient | Amount |
|---|---|
| Lycopene | As per formulation |
| Ginseng Extract | As per formulation |
| Multivitamins | Fortified |
| Multiminerals | Fortified |
The artwork shows a detailed nutritional panel; however, the individual quantities are not clearly legible in the provided image. The composition above reflects the identifiable active ingredients on the packaging.
FAQs (Frequently Asked Questions)
1. What is OXY-NUT-AMRIT Syrup used for?
OXY-NUT-AMRIT is a nutritional supplement formulated to provide antioxidant support while helping maintain immunity, energy, and overall health.
2. Who can consume OXY-NUT-AMRIT Syrup?
It is suitable for adults who wish to supplement their daily nutritional intake. Use as directed by a healthcare professional or certified dietitian.
3. How should OXY-NUT-AMRIT Syrup be stored?
Store in a cool, dry place away from direct sunlight. Shake well before use and keep out of reach of children.
Reviews
There are no reviews yet.